Recent studies have shown that human epidermal growth factor receptor-2 (HER2) expression is elevated in approximately 18–25% of breast cancers [32], and GRP94 is required for both the proper intracellular trafficking and stability of HER2 protein [33]. This evidence concerns the gene HSP90B1 and breast carcinoma.